Abstract
Objective and design
This study investigated if feG-COOH would decrease allergen-induced airway inflammation.
Materials or subjects
Seven adult cats sensitised to Bermuda grass allergen (BGA) to induce an asthmatic phenotype.
Treatment
Cats were randomized to receive either feG-COOH (1 mg/kg, PO) or placebo (saline 1 ml, PO) immediately prior to BGA aerosol challenge in a cross-over design.
Methods
Bronchoalveolar lavage fluid (BALF) was collected and airway inflammatory response assessed via inflammatory cell number and type; IL-4, IFN-γ and nitric oxide metabolite concentrations. A paired t test was used to compare parameters with a P < 0.05 considered significant.
Results
The BALF eosinophil percentage was significantly lower in asthmatic cats treated with feG compared with placebo (placebo, 35.3 ± 12.2%; feG, 22.4 ± 8.6%; P = 0.002). Treatment with feG did not result in a significant change in any other parameter measured.
Conclusions
These data indicate that a single dose of feG-COOH partially attenuates eosinophilic airway inflammation in experimental feline asthma.
Similar content being viewed by others
References
Hill J. Diseases of respiratory organs. In: WR Jenkins, editor. The diseases of the cat. New York; 1906. pp 11–21.
Padrid P. CVT update: feline asthma. In: Bonagura J, editor. Kirk’s current veterinary therapy XIII: small animal practice. Philadelphia: WB Saunders, 2000, pp. 805–10.
Corcoran B, Foster D, Fuentes V. Feline asthma syndrome: a retrospective study of the clinical presentation in 29 cats. J Small Anim Pract. 1995;36:481–8.
Norris Reinero C, Decile K, Berghaus R, Williams K, Leutenegger C, Walby W, et al. An experimental model of allergic asthma in cats sensitized to house dust mite or Bermuda grass allergen. Int Arch Allergy Immunol. 2004;135:117–31.
Dye J, McKiernan B, Rozanski E, et al. Bronchopulmonary disease in the cat: historical, physical, radiographic, clinicopathologic, and pulmonary function evaluation of 24 affected and 15 healthy cats. J Vet Intern Med.. 1996;10:385–400.
Padrid P, Snook S, Finucane T. Persistent airway hyperresponsiveness and histologic alterations after chronic antigen challenge in cats. Am J Respir Crit Care Med. 1995;151:184–93.
Yssel H, Groux H. Characterization of T cell subpopulations involved in the pathogenesis of asthma and allergic diseases. Int Arch Allergy Immunol. 2000;121:10–8.
Feder L, Stelts D, Chapman R, Manfra D, Crawley H, Jones H, et al. Role of nitric oxide on eosinophilic lung inflammation in allergic mice. Am J Respir Cell Mol Biol. 1997;17:436–42.
Sternberg E. Neuroendocrine regulation of autoimmune/inflammatory disease. J Endocrinol. 2001;169:429–35.
Dery R, Mathison R, Davidson J, Befus A. Inhibition of allergic inflammation by C-terminal peptides of the prohormone submandibular rat 1 (SMR-1). Int Arch Allergy Immunol. 2001;124:201–4.
Dery R, Ulanova M, Puttagunta L, Stenton G, James D, Merani S, et al. Inhibition of allergen-induced pulmonary inflammation by the tripeptide feG: a mimetic of a neuro-endocrine pathway. Eur J Immunol. 2004;34:3315–25.
Hawkins E, DeNicola D, Kuehn N. Bronchoalveolar lavage in the evaluation of pulmonary disease in the dog and cat: state of the art. J Vet Intern Med. 1990;4:267–74.
Bay J, Johnson L. Feline bronchial disease/asthma. In: King L, editor. Textbook of respiratory disease in dogs and cats. St. Louis: Elsevier; 2004. p. 388–96.
Padrid P. Feline asthma. Diagnosis and treatment. Vet Clin North Am Small Anim Pract. 2000;30:1279–93.
Cohn L, Elias J, Chupp G. Asthma: mechanisms of disease persistence and progression. Ann Rev Immunol. 2004;22:789–815.
Ramaswamy K, Mathison R, Carter L, Kirk D, Green F, Davison J, et al. Marked antiinflammatory effects of decentralization of the superior cervical ganglia. J Exp Med. 1990;172:1819–30.
Mathison R, Davidson J, De Sanctis G, Green F, Befus A. Decentralization of the superior cervical ganglia and the immediate hypersensitivity response. Proc Soc Exp Biol Med. 1992;200:542–7.
Kemp A, Mellow L, Sabbadini E. Suppression and enhancement of in vitro lymphocyte reactivity by factors in rat submandibular gland extracts. Immunology. 1985;56:261–7.
Reinero C, Cohn L, Delgado C, Spinka C, Schooley E, DeClue A. Adjuvanted rush immunotherapy using CpG oligodeoxynucleotides in experimental feline allergic asthma. Vet Immunol Immunopathol. 2008;121:241–50.
Richardson J, Beland J. Nonadrenergic inhibitory nervous system in human airways. J Appl Physiol. 1976;41:764–71.
Irvin C, Boileau R, Tremblay J, Martin R, Macklem P. Bronchodilatation: noncholinergic, nonadrenergic mediation demonstrated in vivo in the cat. Science. 1980;207:791–2.
Diamond L, O’Donnell M. A nonadrenergic vagal inhibitory pathway to feline airways. Science. 1980;208:185–8.
Diamond L, Szarek J, Gillespie M, Altiere R. In vivo bronchodilatory activity of vasoactive intestinal peptide in the cat. Am Rev Respir Dis. 1983;128:827–32.
Takahashi N, Tanaka H, Abdullah N, Jing L, Inoue R, Ito Y. Regional difference in the distribution of L-NAME-sensitive and -insensitive NANC relaxations in cat airway. J Physiol. 1995;488:709–20.
Jang L, Inoue R, Tashiro K, Takahashi S, Ito Y. Role of nitric oxide in non-adrenergic, non-cholinergic relaxation and modulation of excitatory neuroeffector transmission in the cat airway. J Physiol. 1995;483:225–37.
van der Velden V, Hulsmann A. Autonomic innervation of human airways: structure, function and pathophysiology in asthma. Neuroimmunomodulation. 1999;6:145–59.
Shaw D, Berry M, Thomas M, Green R, Brightling C, Wardlaw A, et al. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am J Repir Crit Care Med. 2007;176:231–7.
Kumar L, Rajput N, Majumdar S. Nitric oxide metabolites in induced sputum: a noninvasive marker of airway inflammation in asthma. Indian Pediatr. 2005;42:329–37.
Acknowledgments
The authors would like to thank Craig Woods and Imulan BioTherapeutics for their generous donation of feG-COOH. Additionally, the authors appreciate the assistance of Rachael Cohen this project.
Author information
Authors and Affiliations
Corresponding author
Additional information
Responsible Editor: M. Parnham.
Rights and permissions
About this article
Cite this article
DeClue, A.E., Schooley, E., Nafe, L.A. et al. feG-COOH blunts eosinophilic airway inflammation in a feline model of allergic asthma. Inflamm. Res. 58, 457–462 (2009). https://doi.org/10.1007/s00011-009-0010-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00011-009-0010-1